台股 » 個股 » 訊聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

訊聯

(1784)
可現股當沖
  • 股價
    90.0
  • 漲跌
    ▲1.0
  • 漲幅
    +1.12%
  • 成交量
    512
  • 產業
    上櫃 生技醫療類股
  • 117人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
訊聯 (1784)籌碼相關-元大-大益 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw03/0803/1803/2804/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0202/1202/247580859095May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

元大-大益 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/26288.60990.0889.50-7228-3.07%
2025/03/2500.00188.5088.50-1224-0.44%
2025/03/21086.2000.0086.2002210.00%
2025/03/2000.00184.2084.40-1228-0.44%
2025/03/1900.00181.4082.70-1236-0.42%
2025/03/18381.1000.0081.5032471.21%
2025/03/1700.000.178.7078.80-0.1257-0.02%
2025/03/1100.000.178.7079.10-0.1287-0.04%
2025/03/100.280.5000.0080.100.23230.05%
2025/03/03183.400.283.7083.400.83550.22%
2025/02/26185.1000.0085.1013760.27%
2025/02/2500.00184.7085.50-1379-0.26%
2025/02/24185.6000.0085.1014090.24%
2025/02/21286.05087.2085.5024320.45%
2025/02/17184.600.183.7084.000.94280.22%
2025/02/14184.1000.0084.1014310.23%
2025/02/1300.00184.3084.10-1434-0.23%
2025/02/12183.7000.0083.0014380.23%
2025/01/1700.000.181.5181.00-0.1446-0.01%
2025/01/1500.00081.8081.900460-0.01%
2025/01/1000.00181.6082.60-1451-0.22%
2025/01/071.481.9200.0082.001.44670.29%
2025/01/06180.00481.7381.50-3475-0.63%
2024/12/30179.7000.0079.5014910.20%
2024/12/270.580.9000.0080.100.54950.10%
2024/12/2600.00381.9080.90-3525-0.57%
2024/12/24380.1000.0080.0035270.57%
2024/12/17183.6000.0083.4015820.17%
2024/12/16284.6900.0082.0025980.34%
2024/12/1300.00192.2087.20-1587-0.17%
2024/12/12196.20198.1092.6005800.00%
2024/12/10193.6000.0093.8015590.18%
2024/12/0400.003.199.52100.50-3.1550-0.56%
2024/12/0200.00395.9796.50-3523-0.57%
2024/11/29394.20191.7097.0025190.39%
2024/11/28190.6000.0090.6015120.20%
2024/11/2600.00295.6095.20-2538-0.37%
2024/11/25195.70197.8097.4005650.00%
2024/11/21595.1200.0093.3055840.86%
2024/11/20196.50195.6095.9005650.00%
2024/11/1900.003.288.3588.80-3.2570-0.57%
2024/11/1800.00188.2088.70-1627-0.16%
2024/11/14188.50190.8088.4006350.00%
2024/11/12190.1000.0089.1016530.15%
2024/11/1100.00193.0092.60-1673-0.15%
2024/11/080.395.0800.0094.100.37110.05%
2024/11/06190.9000.0091.5017290.14%
2024/11/040.290.7000.0090.800.27910.02%
2024/11/010.491.0000.0091.200.48240.04%
2024/10/2800.000.895.1093.50-0.8879-0.09%
2024/10/25094.80095.1094.8009270.00%
2024/10/24197.0000.0096.2019830.10%
2024/10/232101.50499.8099.80-21,012-0.20%
2024/10/2200.00195.3097.40-11,067-0.09%
2024/10/18193.4000.0093.1011,4300.07%
2024/10/163.195.76298.0094.501.11,5540.07%
2024/10/110.593.000.194.0090.900.41,5710.03%
2024/10/09096.2000.0096.1001,5850.00%
2024/10/0800.00398.3398.00-31,594-0.19%
2024/10/071100.5000.0099.4011,6420.06%
2024/10/041.598.4600.0098.801.51,6850.09%
2024/10/010.5102.0000.00102.000.51,6870.03%
2024/09/302104.981104.50100.0011,7060.06%
2024/09/2700.00199.0098.90-11,756-0.06%
2024/09/242.198.400.196.9096.6022,2460.09%
2024/09/2300.001101.50100.00-12,243-0.04%
2024/09/191104.5000.00102.5012,2880.04%
2024/09/1600.001.8105.16106.00-1.82,298-0.08%
2024/09/1000.002103.00103.00-22,475-0.08%
2024/09/090106.0000.00105.5002,4990.00%
2024/09/061106.0000.00105.5012,5510.04%
2024/09/051109.0000.00105.5012,5660.04%
2024/09/0400.001109.50109.00-12,594-0.04%
2024/08/292.2119.6100.00118.002.22,8210.08%
2024/08/2800.003121.00119.00-32,888-0.10%
2024/08/264119.502118.75120.5022,9860.07%
2024/08/231115.0000.00115.0013,0100.03%
2024/08/2200.001118.00114.50-13,003-0.03%
2024/08/211115.002118.00117.00-12,998-0.03%
2024/08/201.1116.641116.00116.000.12,9730.00%
2024/08/1600.001113.50113.00-12,933-0.03%
2024/08/151112.0000.00113.0012,9360.03%
2024/08/141113.001111.00112.0002,9560.00%
2024/08/080106.0000.00106.0002,9180.00%
2024/08/064.199.932103.00103.002.12,8900.07%
2024/08/051.299.723100.5099.50-1.92,853-0.06%
2024/08/020.1112.5000.00110.500.12,8180.00%
2024/08/010.1119.501120.50117.00-0.92,802-0.03%
2024/07/310.1114.5000.00114.500.12,7900.00%
2024/07/301115.5000.00116.5012,7790.04%
2024/07/290.2115.833116.33113.50-2.92,748-0.10%
2024/07/260.1126.001.1126.94126.00-12,692-0.04%
2024/07/236.1137.992132.00132.004.12,6660.15%
2024/07/221.1139.9000.00136.001.12,6470.04%
2024/07/199.1154.932158.62145.5072,5720.27%
2024/07/180158.002156.75161.50-22,302-0.09%
2024/07/172144.5000.00147.0022,2110.09%
2024/07/1600.001145.00141.50-12,198-0.05%
2024/07/1500.001142.50143.50-12,196-0.05%
2024/07/111140.5000.00140.0012,1630.05%
2024/07/092147.570156.00143.5022,1300.09%
2024/07/080135.501.1142.76146.00-1.12,083-0.05%
2024/07/050.1134.0000.00133.000.12,0390.00%
2024/07/042133.7500.00135.5022,0270.10%
2024/07/031138.503138.50133.00-22,008-0.10%
2024/07/025.2134.042139.25140.003.21,9350.17%
2024/07/012128.004131.63139.50-21,729-0.12%
2024/06/281127.003126.00127.00-21,623-0.12%
2024/06/2700.001115.50115.50-11,436-0.07%
2024/06/21197.5000.0093.7011,3510.07%
2024/06/190.195.100.196.9394.20-0.11,2790.00%
2024/06/180.297.090.198.2896.100.11,2420.00%
2024/06/170.195.101792.1891.50-171,195-1.42%
2024/06/140.188.2400.0087.700.11,1530.00%
2024/06/13488.8000.0085.3041,1250.36%
2024/06/110.285.93186.9082.80-0.91,051-0.08%
2024/06/06184.8000.0081.2019690.10%
2024/06/040.180.500.185.1080.0008360.00%
2024/06/031.184.8900.0085.001.17730.14%
2024/05/310.282.3100.0082.400.26900.02%
2024/05/301.177.31175.0077.300.16070.01%
2024/05/29073.00169.2074.00-1547-0.18%
2024/05/28168.6000.0068.8014980.20%
2024/05/2700.00168.9068.60-1496-0.20%
2024/05/24166.9000.0067.2014930.20%
2024/05/17169.71171.0069.9004540.01%
2024/05/0200.001666.9966.50-16380-4.20%
2024/04/29665.9000.0065.1063621.66%
2024/04/26367.90371.5066.4003550.00%
2024/04/25067.2000.0069.4003090.00%
2024/04/231.161.18164.9064.100.12880.02%
2024/04/22063.5000.0060.8002780.01%
2024/04/15163.5000.0063.6012780.36%
2024/04/12164.3000.0064.0012760.36%
2024/04/03164.0000.0064.5012620.38%
2024/04/02162.8000.0065.3012570.39%
2024/04/01262.40162.2063.0012540.39%
訊聯2024年外泌體與幹細胞趨勢論壇 聚焦羊水與臍帶血應用Anue鉅亨-2024/12/25
訊聯H1外泌體業績年增1.8倍 旗下訊聯細胞智藥擬Q4登興櫃Anue鉅亨-2024/08/26
訊聯 相關文章
訊聯 相關影音